Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

OTHER × Birt-Hogg-Dube Syndrome × Sirolimus × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Precursor Cell Lymphoblastic Leukemia-Lymphoma 31 Myelodysplastic Syndromes 27 Leukemia, Myeloid, Acute 27 Hodgkin Disease 24 Lymphoma, Non-Hodgkin 23 Multiple Myeloma 22 Lymphoma 20 Leukemia 20 Graft vs Host Disease 20 Leukemia, Lymphocytic, Chronic, B-Cell 19 Leukemia, Myelogenous, Chronic, BCR-ABL Positive 15 Myeloproliferative Disorders 14 Lymphoma, Mantle-Cell 14 Tuberous Sclerosis 12 Neoplasms 12 Lymphoma, Large B-Cell, Diffuse 12 Hematologic Neoplasms 12 Burkitt Lymphoma 12 Primary Myelofibrosis 11 Recurrence 10 Neoplasms, Plasma Cell 10 Lymphoma, Follicular 10 Leukemia, Myelomonocytic, Chronic 10 Waldenstrom Macroglobulinemia 9 Sarcoma 9 Neoplasm Metastasis 9 Lymphoma, B-Cell, Marginal Zone 9 Lymphangioleiomyomatosis 9 Leukemia, Myeloid, Chronic-Phase 9 Leukemia, Myeloid, Accelerated Phase 9

Interventions

Sirolimus 1 Blood Specimen Collection 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT00928798 2012-03-08

Topical Rapamycin for Fibrofolliculomas

Maastricht University Medical Center

Phase 3 Completed

Birt-Hogg-Dube Syndrome

Data powered by HemOnc (CC BY 4.0) Colophon ⚡